1.Zhang JZ*, Belbachir N*, Zhang T*, Liu Y, Shrestha R, Wu JC. (2021). Effect of Cryopreservation on Human iPSC-Derived Cardiomyocytes for Assessing Drug Safety Response Profiles.Stem Cell Reports, 16(1):168-181. (* Co-first author)

2.Zhang JZ, Termglinchan V, Shao NY, Itzhaki I, Liu C, Ma N, Tian L, Wang VY, Chang ACY, Guo H, Kitani T, Wu H, Lam CK, Kodo K, Sayed N, Blau HM, Wu JC. (2019). A Human iPSC Double-Reporter System Enables Purification of Cardiac Lineage Subpopulations with Distinct Function and Drug Response Profiles.Cell Stem Cell, 24(5): 802-811.e5.

3. Ma N*,Zhang JZ*, Itzhaki I*, Zhang SL, Chen H, Haddad F, Kitani T, Wilson KD, Tian L, Shrestha R, Wu H, Lam CK, Sayed N, Wu JC. (2018). Determining the Pathogenicity of a Genomic Variant of Uncertain Significance Using CRISPR/Cas9 and Human Induced Pluripotent Stem Cells.Circulation, 138(23):2666-2681. (* Co-first author)

4.Zhang JZ, Guo HC, Wu JC. (2018). Applications of genetically engineered human pluripotent stem cell reporters in cardiac stem cell biology.Current Opinion in Biotechnology, 52:66-73.

5.Zhang JZ, Waddell HM, Wu E, Dholakia J, Okolo CA, McLay JC, Jones PP. (2016). FKBPs facilitate the termination of spontaneous Ca2+ release in wild-type RyR2 but not CPVT mutant RyR2.Biochemical Journal, 473(14), 2049-60.